The Course of General Cognitive Ability in Individuals With Psychotic Disorders.
Journal
JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550
Informations de publication
Date de publication:
01 07 2022
01 07 2022
Historique:
pubmed:
19
5
2022
medline:
9
7
2022
entrez:
18
5
2022
Statut:
ppublish
Résumé
Schizophrenia is associated with major cognitive deficits and has been conceptualized as both a neurodevelopmental and a neurodegenerative disorder. However, when deficits develop and how they change over the course of illness is uncertain. To trace cognition from elementary school to old age to test neurodevelopmental and neurodegenerative theories of psychotic disorders. Data were taken from the Suffolk County Mental Health Project, a first-admission longitudinal cohort study of individuals with psychotic disorders. Participants were recruited from all 12 inpatient psychiatric facilities in Suffolk County, New York. This analysis concerns the 428 participants with at least 2 estimates of general cognitive ability. Data were collected between September 1989 and October 2019, and data were analyzed from January 2020 to October 2021. Psychiatric hospitalization for psychosis. Preadmission cognitive scores were extracted from school and medical records. Postonset cognitive scores were based on neuropsychological testing at 6-month, 24-month, 20-year, and 25-year follow-ups. Of the 428 included individuals (212 with schizophrenia and 216 with other psychotic disorders), 254 (59.6%) were male, and the mean (SD) age at psychosis onset was 27 (9) years. Three phases of cognitive change were observed: normative, declining, and deteriorating. In the first phase, cognition was stable. Fourteen years before psychosis onset, those with schizophrenia began to experience cognitive decline at a rate of 0.35 intelligence quotient (IQ) points per year (95% CI, 0.29-0.42; P < .001), a significantly faster decline than those with other psychotic disorders (0.15 IQ points per year; 95% CI, 0.08-0.22, P < .001). At 22 years after onset, both groups declined at a rate of 0.59 IQ points per year (95% CI, 0.25-0.94; P < .001). In this cohort study, cognitive trajectories in schizophrenia were consistent with both a neurodevelopmental and neurodegenerative pattern, resulting in a loss of 16 IQ points over the period of observation. Cognitive decline began long prior to psychosis onset, suggesting the window for primary prevention is earlier than previously thought. A window for secondary prevention emerges in the third decade of illness, when cognitive declines accelerate in individuals with schizophrenia and other psychotic disorders.
Identifiants
pubmed: 35583896
pii: 2792520
doi: 10.1001/jamapsychiatry.2022.1142
pmc: PMC9118026
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
659-666Subventions
Organisme : NIMH NIH HHS
ID : R01 MH094398
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH110434
Pays : United States
Références
Transl Psychiatry. 2015 Aug 18;5:e623
pubmed: 26285133
Schizophr Bull. 2013 Sep;39(5):993-8
pubmed: 23821768
Schizophr Bull. 2019 Sep 11;45(5):1101-1111
pubmed: 30321434
Am J Psychiatry. 2011 Nov;168(11):1186-94
pubmed: 21676994
Schizophr Bull. 2000;26(1):119-36
pubmed: 10755673
Schizophr Bull. 2008 Mar;34(2):312-21
pubmed: 18263882
JAMA Psychiatry. 2021 Jun 16;:
pubmed: 34132736
Mol Psychiatry. 2012 Dec;17(12):1228-38
pubmed: 22488257
Am J Psychiatry. 2020 Apr 1;177(4):327-334
pubmed: 32046533
Age Ageing. 2011 Nov;40(6):684-9
pubmed: 21890481
Schizophr Bull. 2015 Sep;41(5):1095-104
pubmed: 25616505
JAMA Psychiatry. 2018 Mar 1;75(3):270-279
pubmed: 29387877
Mol Psychiatry. 2021 Aug;26(8):4529-4543
pubmed: 33414498
Arch Gen Psychiatry. 2004 Apr;61(4):354-60
pubmed: 15066893
Psychol Med. 2019 Jan;49(2):232-242
pubmed: 29564993
Arch Gen Psychiatry. 2007 Jun;64(6):633-47
pubmed: 17548746
Bipolar Disord. 2020 Feb;22(1):13-27
pubmed: 31408230
JAMA Neurol. 2017 Jul 1;74(7):830-838
pubmed: 28558099
Schizophr Bull. 2014 Jul;40(4):744-55
pubmed: 23770934
JAMA Psychiatry. 2018 Apr 1;75(4):356-362
pubmed: 29450471
Am J Psychiatry. 2017 Nov 1;174(11):1075-1085
pubmed: 27978770
Schizophr Bull. 1992;18(2):243-55
pubmed: 1621071
J Abnorm Psychol. 2016 Nov;125(8):1103-1119
pubmed: 27819471
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Neuropsychol Rev. 2018 Dec;28(4):509-533
pubmed: 30343458
Schizophr Bull. 2022 May 7;48(3):590-598
pubmed: 35064259
J Clin Psychiatry. 2012 Jul;73(7):e899-905
pubmed: 22901360
JAMA Psychiatry. 2020 Apr 1;77(4):387-396
pubmed: 31825511
Neuropsychology. 2009 May;23(3):315-36
pubmed: 19413446
J Consult Psychol. 1955 Oct;19(5):393-4
pubmed: 13263471
Psychol Rep. 1967 Apr;20(2):523-6
pubmed: 6043021
JAMA Psychiatry. 2013 Oct;70(10):1107-12
pubmed: 23925787
Aust N Z J Psychiatry. 2011 Feb;45(2):93-108
pubmed: 21320033
Am J Psychiatry. 2010 Feb;167(2):160-9
pubmed: 20048021
Stat Methods Med Res. 2016 Oct;25(5):1854-1874
pubmed: 24108269
J Int Neuropsychol Soc. 2009 Sep;15(5):650-61
pubmed: 19570312
Psychol Med. 1995 Jul;25(4):859-68
pubmed: 7480464
Psychol Sci. 2018 Aug;29(8):1358-1369
pubmed: 29911926
Am J Psychiatry. 2008 May;165(5):579-87
pubmed: 18413704
Acta Psychiatr Scand. 2020 Jun;141(6):510-521
pubmed: 31954065
Schizophr Res. 1997 Apr 11;24(3):289-98
pubmed: 9134589
JAMA Psychiatry. 2021 Jun 1;78(6):632-641
pubmed: 33688938
Schizophr Res. 2012 Mar;135(1-3):187-91
pubmed: 22260965
JAMA Psychiatry. 2021 Dec 1;78(12):1305-1306
pubmed: 34524413
Schizophr Res. 2013 May;146(1-3):201-8
pubmed: 23490758
Arch Gen Psychiatry. 2002 May;59(5):449-56
pubmed: 11982449
Compr Psychiatry. 2010 Sep-Oct;51(5):471-9
pubmed: 20728003
Am J Psychiatry. 2019 Oct 1;176(10):811-819
pubmed: 31256609
Psychol Med. 2022 Jan;52(2):217-228
pubmed: 34763735
Schizophr Bull. 2021 Jul 8;47(4):997-1006
pubmed: 33772310